Proficio Capital Partners LLC Vertex Pharmaceuticals Inc Transaction History

Proficio Capital Partners LLC

$969 Million
Q3 2024

A detailed history of Proficio Capital Partners LLC transactions in Vertex Pharmaceuticals Inc stock. As of the latest transaction made, Proficio Capital Partners LLC holds 667 shares of VRTX stock, worth $310,621. This represents 0.03% of its overall portfolio holdings.

Number of Shares

667

Previous 846 21.16%

Holding current value

$310,621

Previous $396,000 21.72%

% of portfolio

0.03%

Previous 0.04%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 01, 2024	SELL	$460.0 - $505.78 $82,340 - $90,534	-179 Reduced 21.16%	667 $310,000
Q2 2024 Jul 25, 2024	BUY	$392.81 - $485.53 $9,034 - $11,167	23 Added 2.79%	846 $396,000
Q1 2024 May 02, 2024	BUY	$407.69 - $446.08 $13,861 - $15,166	34 Added 4.31%	823 $344,000
Q4 2023 Feb 13, 2024	SELL	$343.0 - $410.68 $1,372 - $1,642	-4 Reduced 0.5%	789 $321,000
Q3 2023 Oct 18, 2023	BUY	$338.18 - $362.46 $24,687 - $26,459	73 Added 10.14%	793 $275,000
Q2 2023 Aug 14, 2023	BUY	$314.42 - $351.91 $10,061 - $11,261	32 Added 4.65%	720 $253,000
Q1 2023 Apr 21, 2023	SELL	$283.23 - $323.1 $61.2 Million - $69.8 Million	-216,080 Reduced 99.68%	688 $216,000
Q1 2023 Apr 19, 2023	BUY	$283.23 - $323.1 $61.4 Million - $70 Million	216,768 New	216,768 $68.3 Million
Q4 2020 Feb 11, 2021	SELL	$207.01 - $276.09 $156,706 - $209,000	-757 Closed	0 $0
Q3 2020 Nov 02, 2020	BUY	$255.65 - $303.1 $5,624 - $6,668	22 Added 2.99%	757 $206,000
Q2 2020 Aug 14, 2020	BUY	$225.48 - $295.8 $165,727 - $217,413	735 New	735 $213,000
Q3 2019 Nov 13, 2019	SELL	$166.23 - $187.09 $55,354 - $62,300	-333 Closed	0 $0
Q2 2019 Aug 13, 2019	BUY	$164.61 - $190.37 $2,304 - $2,665	14 Added 4.39%	333 $61,000
Q1 2019 May 13, 2019	BUY	$163.73 - $194.7 $10,806 - $12,850	66 Added 26.09%	319 $59,000
Q4 2018 Feb 08, 2019	SELL	$151.91 - $192.21 $759 - $961	-5 Reduced 1.94%	253 $42,000
Q3 2018 Nov 13, 2018	BUY	$167.73 - $192.74 $1,341 - $1,541	8 Added 3.2%	258 $50,000
Q2 2018 Aug 10, 2018	BUY	$145.72 - $169.96 $1,457 - $1,699	10 Added 4.17%	250 $42,000
Q1 2018 May 14, 2018	SELL	$151.6 - $177.13 $1,212 - $1,417	-8 Reduced 3.23%	240 $39,000
Q4 2017 Feb 09, 2018	SELL	$137.28 - $155.55 $7,138 - $8,088	-52 Reduced 17.33%	248 $37,000
Q3 2017 Nov 14, 2017	BUY	$148.13 - $162.24 $44,439 - $48,672	300	300 $46,000

Others Institutions Holding VRTX

# of Institutions

1,722

Shares Held

222M

Call Options Held

1.58M

Put Options Held

1.36M

View Full List

About VERTEX PHARMACEUTICALS INC

Ticker VRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 256,691,008
Market Cap $120B
Description
Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...

More about VRTX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Proficio Capital Partners LLC, based on Form 13F filings with the SEC.

News

Stay updated on Proficio Capital Partners LLC with notifications on news.

Account

Proficio Capital Partners LLC Vertex Pharmaceuticals Inc Transaction History